Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

TRK-390 as a novel and highly selective phosphate binder

Oct. 8, 2013

AM-Pharma begins phase I trial with new recombinant AP product

Sep. 26, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Relypsa reports data on part A of its phase III patiromer trial

Sep. 16, 2013

ChemoCentryx reports interim data for CCX-140 in patients with diabetic nephropathy

Sep. 13, 2013

Genkyotex obtains IND approval for phase II study of GKT-137831

Sep. 9, 2013

Rockwell Medical reports findings from CRUISE-2 study of SFP

Sep. 5, 2013

Swissmedic opposes approval of Vitaros

Sep. 3, 2013

Fedovapagon tested as potential therapy for nocturia associated with BPH

Sep. 2, 2013

Pilocarpine/tolterodine fixed-dose combination is well tolerated at increased total daily doses

Sep. 2, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...